Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v2.4.0.6
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)
In Thousands
Total
Common Shares [Member]
Paid-in Capital in Excess of par Value [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2009 $ 359,311 $ 120 $ 222,882 $ (23,396) $ 159,705
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 15,309 4 15,305    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 8,045   8,045    
Additional capital from share based compensation 22,969   22,969    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (160,008) (6) (21,088)   (138,914)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (53,740)   580   (54,320)
Net income 299,215       299,215
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively 583     583  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively (4,472)     (4,472)  
Ending Balance at Dec. 31, 2010 487,212 118 248,693 (27,285) 265,686
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 26,467 4 26,463    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 27,450   27,450    
Additional capital from share based compensation 24,133   24,133    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (321,639) (6) (35,427)   (286,206)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (85,489)   638   (86,127)
Net income 412,578       412,578
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively (16,757)     (16,757)  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively 6,233     6,233  
Ending Balance at Dec. 31, 2011 560,188 116 291,950 (37,809) 305,931
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 11,264 3 11,261    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 29,684   29,684    
Additional capital from share based compensation 28,133   28,133    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (556,727) (12) (57,655)   (499,060)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (135,091)   602   (135,693)
Net income 477,190       477,190
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively 9,821     9,821  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively (3,707)     (3,707)  
Ending Balance at Dec. 31, 2012 $ 420,755 $ 107 $ 303,975 $ (31,695) $ 148,368